Skip to main content
. 2021 Feb 4;22(4):1575. doi: 10.3390/ijms22041575

Figure 4.

Figure 4

Molecular docking analysis of the designed blocking polypeptide and key features. (A) The EDA-FN peptide (grey) was docked to the blocking polypeptide (green) derived from the polypeptide with the overall highest scores across all refinement analyses. A 360° rotation is shown to visualize the wrapping and binding of the EDA-FN peptide to the blocking polypeptide, which mimics the integrin α4β17 receptor binding site. Boxed regions I–IV are shown in (B) to highlight the key features of the designed blocking polypeptide. I, the VM cap; II, the ISTTPAK motif of the β17 subunit; III and IV, the C=C disulfide bridge to form the receptor and cage-like conformation; V, the KNENKI motif of the α4 subunit. (C) The antifibrotic 38-amino-acid polypeptide (AF38Pep) polypeptide sequence structure, showing two peptide chains derived from integrins β1 and α4, linked by a serine. Disulfide bridge is shown by a red dashed line, bridging the two cysteines.